J. Berrou

Vascular Health and Risk Management Dovepress Eprosartan-based Hypertension Therapy, Systolic Arterial Blood Pressure and Cognitive Function: Analysis of Middle East Data from the Oscar Study

A. Pathak, G. Radaideh, P. Choueiry, 2022 .

Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study

A. Pathak, A. Goudev, J. Berrou, 2012, Vascular health and risk management.

[Descriptive epidemiological study of acne on scholar pupils in France during autumn 1996].

B. Dréno, P. Humbert, I. Bodokh, 2000, Annales de dermatologie et de venereologie.

Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study

J. Goch, O. Hanon, R. Petrella, 2008, Journal of hypertension.

[ECLA grading: a system of acne classification for every day dermatological practice].

B. Dréno, P. Humbert, I. Bodokh, 1999, Annales de dermatologie et de venereologie.

Blood Pressure Responses to Hypertension Treatment and Trends in Cognitive Function in Patients With Initially Difficult‐to‐Treat Hypertension: A Retrospective Subgroup Analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) Study

R. Petrella, A. Pathak, A. Konradi, 2012, Journal of clinical hypertension.

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey

R. Petrella, D. Gill, J. Berrou, 2015, Diabetes, metabolic syndrome and obesity : targets and therapy.

Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.

L. Tokgözoğlu, Nasreen Alsayed, J. Berrou, 2023, Atherosclerosis.